
Superbio.ai provides a community-driven marketplace that lets life-science teams discover and use AI models and tools for biology. The platform aggregates community-contributed machine learning models, data-science workflows, and biological AI applications into an online store and marketplace. It operates as a software-first marketplace/B2B SaaS platform and offers model-based tools and deployable workflows for researchers and biotech companies. Core technologies include machine learning models and data-science tooling delivered via the marketplace format. The company targets life-science researchers and biotech organizations seeking ready-to-use AI models and analytics.

Superbio.ai provides a community-driven marketplace that lets life-science teams discover and use AI models and tools for biology. The platform aggregates community-contributed machine learning models, data-science workflows, and biological AI applications into an online store and marketplace. It operates as a software-first marketplace/B2B SaaS platform and offers model-based tools and deployable workflows for researchers and biotech companies. Core technologies include machine learning models and data-science tooling delivered via the marketplace format. The company targets life-science researchers and biotech organizations seeking ready-to-use AI models and analytics.
What they do: Community-driven marketplace for AI models and tools for biology (B2B SaaS)
Target customers: Life-science researchers and biotech organizations
Founded: 2021
Funding: Seed round (lead: Mandashi) — Sep 2021 (amount not disclosed)
Notable products: DocChat, ImmuneBuilder (examples of platform apps)
Democratizing machine learning for genomics, structural biology, and drug-discovery workflows via a marketplace of community-contributed models and workflows.
2021
Data and Analytics
“Seed round led by Mandashi; additional angel/syndicate investors listed on some profiles (examples: Stanford Angels, Brown Angel Group, Andy Evans, Sheffield Angels)”